New Zealand Hazardous Substances Compliance Consultant

Scope and evidence must be confirmed before any paid tests or filings.

Decide whether HSNO applies before selecting an approval

A New Zealand hazardous substances compliance consultant should resolve the approval route before commissioning tests, rewriting labels or booking a shipment. The decision concerns the actual substance and its intended use—not merely the product name or an approval number copied from an overseas safety data sheet (SDS).

The practical output is a documented position on HSNO applicability, New Zealand hazard classification, matching approval, evidence gaps and remaining operating controls. A consultant can advise and prepare the analysis; this is not an EPA approval or a guarantee of clearance.

First test whether the material is a hazardous substance under the Hazardous Substances and New Organisms Act 1996 (HSNO) using New Zealand’s adoption of GHS 7. Determine physical, human-health and environmental hazards from reliable data, including mixture composition. A foreign SDS is a starting input, not proof that New Zealand categories or the approval route are correct.

Then check whether a statutory exclusion or exemption is actually applicable. Manufactured articles, ready-to-use human medicines and certain laboratory situations illustrate why the object and activity must be described precisely; their treatment must be assessed rather than assumed. Only after these gates should the team compare current group standards and individual approvals.

Route matrix: existing approval, group standard or new application

Use the matrix as a screening logic, not as a substitute for checking the text and current status of a specific approval.

Finding	Route decision	Critical safeguard
No relevant hazard after supported NZ classification	Record why HSNO hazardous-substance approval is not triggered.	Do not infer that other product, transport or workplace rules disappear.
Formulated product fits a current group standard	Check purpose, physical form, eligible hazards, exclusions, restrictions and component inventory status; assign and retain the rationale.	A group-standard assignment is not an EPA-issued product-by-product certificate.
Substance fits an existing individual approval	Verify the actual substance against its current approval and specific controls.	An HSR number printed on another supplier’s SDS is only a lead, not independent evidence of equivalence.
Hazardous substance fits neither existing route	Evaluate an EPA application for a new release approval or, where appropriate, a group-standard change.	Do not treat a planned application as approval for ordinary import or manufacture.
Research or field trial in controlled conditions	Evaluate a separate containment-approval pathway if applicable.	A containment approval is not a general release authorisation and cannot simply be assigned to an unrelated product.

Before using the group-standard branch, apply the high-risk product gate. EPA identifies fuels, explosives, pesticides, vertebrate toxic agents, fumigants, antifouling paints and timber treatments as categories normally requiring individual approvals rather than group standards. Certain veterinary medicines may fit veterinary-medicine group standards: decide by the exact product, active ingredient, use and current approval text, not a generic category name.

For mixtures, apply a separate CMR/NZIoC stop rule. Under the EPA's group-standard guidance, if the product has relevant category 1 or 2 carcinogenicity, germ-cell mutagenicity or reproductive-toxicity hazards (including effects on or via lactation), check every component responsible for those classifications against NZIoC. An unlisted triggering component generally prevents group-standard assignment; EPA notes a narrow reformulation exception on which it should be consulted. Other unlisted components may require EPA notification before assignment; such notification does not cure an ineligible group-standard scope.

Individual-approval match for biocides: For a pesticide or other biocidal product, matching the active ingredient name is not enough. Check the active-ingredient concentration against the EPA’s published tolerances, and compare hazard classification, physical state/form and permitted use with the current individual approval. If the match fails, do not reuse the earlier HSR number; contact EPA about a new approval.

Pure-chemical NZIoC stop: A listing that permits an ingredient only as a component of a product covered by a group standard does not authorise importing or selling that chemical on its own. EPA directs operators in that position to contact it about a separate HSNO approval; do not treat an ingredient notification or the inventory entry as that approval.

Evidence intake: what changes the route

Request a controlled file for the exact formulation and version proposed for New Zealand. Identify what is verified, supplier-stated or unknown.

Evidence to collect	Decision it unlocks	If unavailable
Full formulation; CAS identities, concentration ranges and impurities	Mixture classification and verification of NZIoC component restrictions	Get confidential supplier disclosure under suitable access controls; hold classification.
Test reports, physical properties, toxicology/ecotoxicology and dated SDS	NZ GHS 7 classifications and classification-confidence assessment	Document gaps; ask a qualified classifier whether justified bridging/data is sufficient before ordering tests.
Intended use, claims, physical form, packaging and end users	Group-standard scope, separate regulator and controls	Freeze market claims and variants until route is checked.
Any cited HSNO approval/HSR code and full current approval conditions	Existing-approval match, including conditions and revocations	Retrieve the current EPA approval; do not rely on an isolated code.
Component CAS cross-checks against NZIoC and listed status	Ingredient notification or single-chemical individual-approval question	Resolve status: listing does not alone approve every use or a pure-chemical sale.
NZ importer/manufacturer identity, NZBN, first activity dates, volumes and storage scenario	HSRN duties, possible annual reports and WorkSafe workplace design	Nominate an accountable operator; keep quantities and site facts provisional until confirmed.

A gap analysis that separates blocked decisions from document work

Separate a classification gap (hazard unknown), a legal-fit gap (scope or approval mismatch), a data gap (weak evidence), and an implementation gap (SDS, label, packaging, notifications or workplace controls). They demand different remedies; ordering a laboratory test does not resolve a missing approval scope.

Overseas data may be reusable when identity, formulation, endpoint, method and reliability match the NZ question. Reusing an overseas GHS category without checking the NZ adopted categories, current EPA notices and actual mixture may create a false route decision.

Overseas SDS/label reuse is conditional, not prohibited. EPA's alternative-compliance provisions may accept qualifying EU, Australian, Canadian or US SDS and labels with mandatory New Zealand information added. Before import or manufacture, an importer/manufacturer relying on those provisions must record the foreign jurisdiction and supporting compliance basis and retain the record for at least two years after the substance is no longer supplied in New Zealand. Recognition of overseas packaging requirements is narrower: it concerns specified child-resistance and permanent-identification requirements, with excluded hazard classes. A UK-only SDS is not itself a recognised alternative jurisdiction. Check the current notices before paying for a complete rewrite or assuming foreign documents are sufficient.

2026 importer reporting and downstream controls

From 1 January 2026, the EPA Importers and Manufacturers Notice requires importers and manufacturers of hazardous substances to give business details via the HSRN portal within 30 days of first import or manufacture, including NZBN and relevant HSNO approval numbers/names; updates, including new substances, are also due within 30 days of a change. Only specified substances trigger annual quantity reporting; where applicable, the preceding calendar year’s report is due by 31 May. These reporting steps do not themselves grant approval. Check the Notice’s scope: personal-use activity, offshore exporters and specified laboratories can fall outside these reporting obligations.

Approval is only one layer. Check the applicable EPA notices and approval-specific controls for a New Zealand-compliant 16-section SDS, English labelling and packaging; the earlier GHS-related SDS transition ended on 30 April 2025. At workplaces, WorkSafe rules may require inventories, risk controls and other measures according to the substance and site quantities.

HSRN business details are approval-level reporting, not product-by-product certification: EPA says an approval normally needs to be reported only once even if several products use it. Where an operator has no NZBN, EPA invites discussion of alternative portal access. The 30-day HSRN deadline follows a qualifying first import/manufacture; it does not permit an unapproved substance to be imported or manufactured in the meantime.

When another regulator or specialist owns the next step

If the substance is an agricultural chemical, veterinary medicine or pesticide, assess MPI/ACVM obligations alongside any required HSNO approval; do not replace an ACVM decision with an EPA group-standard assumption. For medical devices, determine whether the Medsafe/WAND system is relevant; WAND notification is not EPA hazardous-substance approval.

This page owns the hazardous-substance route strategy, not the whole country market-access map or a medical-device filing manual. For adjacent work, see New Zealand product-market access overview, Medsafe device notification, and general product-compliance advisory.

The consultant’s decision deliverable and safe order of work

1. Freeze identity — Record formulation revision, use, pack size and market claim; identify which changes require re-screening.
2. Classify for New Zealand — Map defensible endpoint data to the NZ GHS 7 classification system and log uncertainty.
3. Prove approval fit — Compare the whole scope and controls of current candidate approvals; log the exact basis for assignment or the new-approval gap.
4. Close the release blockers — Resolve ingredient status, evidence needs and any parallel regulator before commissioning downstream production work.
5. Hand off obligations — Allocate owner, dated assignment record, SDS, label, packaging, HSRN and workplace-control checks; re-open on changes.

Ask the consultant for a version-controlled route memo: product identity; HSNO trigger/exemption analysis; NZ hazard classes and evidence quality; candidate HSR approval and clause-by-clause fit; NZIoC exceptions; named open questions; and one recommended next action with a no-go condition. This is a proposed professional deliverable, not a statutory document.

A responsible recommendation may be “do not import yet; obtain formulation data”, “document a defensible group-standard assignment”, “verify individual approval equivalence with EPA”, or “plan a new-approval application”. The right answer depends on facts; neither a foreign approval nor an SDS by itself settles it.

Decision principle: confirm substance identity and legal approval route first; spend on testing, packaging or filing only to close a defined, material gap.

Decision-specific questions

Does an Australian or EU SDS establish New Zealand approval?

No. It can supply useful test and classification evidence, but the mixture, NZ GHS 7 classes, HSNO approval scope and NZ-specific SDS details still need review.

Does an NZIoC entry mean my pure chemical can be sold?

No. If NZIoC lists the chemical only for use as a component in a group-standard product, that entry does not cover separate sale as a pure chemical. EPA says to contact it about a separate HSNO approval before choosing that route.

Must EPA issue a certificate for every group-standard product?

Not generally. Eligible products can be assigned to an existing group standard with a recorded justification; regulatory reporting and all conditions still apply. A paid formal EPA determination is a separate option for uncertainty.

Can I reuse an approval after changing a solvent concentration?

Do not assume so. Recheck mixture classification, group scope or individual-approval identity, NZIoC status, SDS and controls against the revised formula.

Can a field-trial containment approval support retail sales?

No. Containment approval is a distinct restricted-use route; ordinary release needs an applicable release approval.

Does HSRN registration replace HSNO approval or WorkSafe duties?

No. HSRN transmits importer/manufacturer information; it neither creates a substance approval nor displaces applicable workplace controls.